IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

University of Zurich (UZH)

Status: Completed

Conditions: Allergy to Cats

Treatments: Behavioral: Blood sample

Study type: Observational

Funder types: Other

Identifiers

NCT00620880

IVN-CAT-001A

Details and patient eligibility

About

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria: 1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years

Exclusion criteria: 1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander